120 related articles for article (PubMed ID: 36595963)
1. Protocol for production and expression of chimeric bovine-human monoclonal antibodies.
Heydarchi B; Purcell DFJ
STAR Protoc; 2022 Dec; 3(4):101911. PubMed ID: 36595963
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies.
Edwards JM; Heydarchi B; Khoury G; Salazar-Quiroz NA; Gonelli CA; Wines B; Hogarth PM; Kristensen AB; Parsons MS; Purcell DFJ
J Virol; 2021 Jun; 95(13):e0021921. PubMed ID: 33853957
[TBL] [Abstract][Full Text] [Related]
3. [Identification of Env-specific monoclonal antibodies from Chinese HIV-1 infected person by magnetic beads separating B cells and single cell RT-PCR cloning].
Huang XY; Yu SQ; Cheng Z; Ye JR; Xu K; Feng X; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr; 27(2):123-5. PubMed ID: 24044218
[TBL] [Abstract][Full Text] [Related]
4. Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env.
Heydarchi B; Center RJ; Bebbington J; Cuthbertson J; Gonelli C; Khoury G; Mackenzie C; Lichtfuss M; Rawlin G; Muller B; Purcell D
MAbs; 2017 Apr; 9(3):550-566. PubMed ID: 27996375
[TBL] [Abstract][Full Text] [Related]
5. Sequencing, cloning, and antigen binding analysis of monoclonal antibodies isolated from single mouse B cells.
Viant C; Escolano A; Chen ST; Nussenzweig MC
STAR Protoc; 2021 Jun; 2(2):100389. PubMed ID: 33778783
[TBL] [Abstract][Full Text] [Related]
6. Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins.
Li A; Baba TW; Sodroski J; Zolla-Pazner S; Gorny MK; Robinson J; Posner MR; Katinger H; Barbas CF; Burton DR; Chou TC; Ruprecht RM
AIDS Res Hum Retroviruses; 1997 May; 13(8):647-56. PubMed ID: 9168233
[TBL] [Abstract][Full Text] [Related]
7. [Identification of Env-specific monoclonal antibodies from Chinese HIV-1 infected person by B cell activation and RT-PCR cloning].
Wang HM; Xu K; Yu SQ; Ding LL; Luo HY; Flinko R; Lewis GK; Feng X; Shao JR; Guan YJ; Zeng Y
Bing Du Xue Bao; 2012 Jun; 28(4):358-65. PubMed ID: 22978159
[TBL] [Abstract][Full Text] [Related]
8. The Construction and Characterization of 1F5 Chimeric Anti-CD20 Monoclonal Antibodies: An Efficient Splicing by Overlap Extension-polymerase Chain Reaction Technique.
Khademi F; Mohammadi P; Mostafaei A
Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):205-220. PubMed ID: 33904679
[TBL] [Abstract][Full Text] [Related]
9. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.
Tiller T; Meffre E; Yurasov S; Tsuiji M; Nussenzweig MC; Wardemann H
J Immunol Methods; 2008 Jan; 329(1-2):112-24. PubMed ID: 17996249
[TBL] [Abstract][Full Text] [Related]
10. Production and purification of recombinant monoclonal antibodies from human cells based on a primary sequence.
DeLuca KF; Mick JE; DeLuca JG
STAR Protoc; 2022 Dec; 3(4):101915. PubMed ID: 36595892
[TBL] [Abstract][Full Text] [Related]
11. A method for the isolation and characterization of functional murine monoclonal antibodies by single B cell cloning.
Carbonetti S; Oliver BG; Vigdorovich V; Dambrauskas N; Sack B; Bergl E; Kappe SHI; Sather DN
J Immunol Methods; 2017 Sep; 448():66-73. PubMed ID: 28554543
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose?
Ehlers AM; den Hartog Jager CF; Kardol-Hoefnagel T; Katsburg MMD; Knulst AC; Otten HG
Front Immunol; 2021; 12():660037. PubMed ID: 34017336
[TBL] [Abstract][Full Text] [Related]
13. A Protocol for Studying HIV-1 Envelope Glycoprotein Function.
Ratnapriya S; Chov A; Herschhorn A
STAR Protoc; 2020 Dec; 1(3):100133. PubMed ID: 33377027
[TBL] [Abstract][Full Text] [Related]
14. Clonal analysis of human anti-V3 monoclonal antibodies selected by a V3 tetramer.
Li L; Wang XH; Banerjee S; Volsky B; Williams C; Moody MA; Zolla-Pazner S; Gorny MK
Hum Antibodies; 2012; 21(3-4):65-73. PubMed ID: 23549023
[TBL] [Abstract][Full Text] [Related]
15. Two-phase approach for the expression of high-affinity human anti-human immunodeficiency virus immunoglobulin Fab domains in Escherichia coli.
Takeda S; Dorfman NA; Robert-Guroff M; Notkins AL; Rando RF
Hybridoma; 1995 Feb; 14(1):9-18. PubMed ID: 7768538
[TBL] [Abstract][Full Text] [Related]
16. Protocol to identify and monitor key mutations of broadly neutralizing antibody lineages following sequential immunization of Ig-humanized mice.
Chen X; Schmidt SD; Duan H; Doria-Rose NA; Mascola JR
STAR Protoc; 2022 Mar; 3(1):101180. PubMed ID: 35243372
[TBL] [Abstract][Full Text] [Related]
17. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.
Smith K; Garman L; Wrammert J; Zheng NY; Capra JD; Ahmed R; Wilson PC
Nat Protoc; 2009; 4(3):372-84. PubMed ID: 19247287
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virus.
Shepherd AJ; Boyd JE; Hogg CL; Aw D; James K
Hum Antibodies Hybridomas; 1992 Oct; 3(4):168-76. PubMed ID: 1335786
[TBL] [Abstract][Full Text] [Related]
19. Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape.
Suryadevara N; Gilchuk P; Zost SJ; Mittal N; Zhao LL; Crowe JE; Carnahan RH
STAR Protoc; 2022 Jun; 3(2):101387. PubMed ID: 35578733
[TBL] [Abstract][Full Text] [Related]
20. [Use of monoclonal antibodies against human HLA II antigens for the detection of bovine B lymphocytes and macrophages].
Dusinský R; Simon M; Ujházyová J; Poláková K
Vet Med (Praha); 1992; 37(9-10):549-54. PubMed ID: 1292177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
